As of January 2025 Neuren Pharmaceuticals has a market cap of S$1.31 Billion. This makes Neuren Pharmaceuticals the world's 5635th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | S$1.31 B | -2.96% |
2024 | S$1.35 B | -53.21% |
2023 | S$2.89 B | 209.79% |
2022 | S$0.93 B | 96.28% |
2021 | S$0.47 B | 209.97% |
2020 | S$0.15 B | -36.03% |
2019 | S$0.24 B | 73.74% |
2018 | S$0.13 B | -55.05% |
2017 | S$0.30 B | 176.11% |
2016 | S$0.11 B | -46.77% |
2015 | S$0.20 B | -0.71% |
2014 | S$0.21 B | 7.29% |
2013 | S$0.19 B | 273.65% |
2012 | S$52.6 M | 26.95% |
2011 | S$41.44 M | 366.02% |
2010 | S$8.89 M | -45.9% |
2009 | S$16.43 M | 532.73% |
2008 | S$2.59 M | -92.07% |
2007 | S$32.77 M | -39.47% |
2006 | S$54.15 M | -14.5% |
2005 | S$63.33 M |